- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
GlaxoSmithKline PLC
Add to PortfolioGSK:US
44.2800 USD 0.0400 0.09%As of 20:04:07 ET on 05/25/2012.
Snapshot for GlaxoSmithKline PLC (GSK)
| Open: | 44.2000 | Day's Range: | 44.1500 - 44.4600 | Volume: | 2,242,085 | Bid: | 44.2900 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 44.2400 | 52wk Range: | 38.6387 - 47.4800 | 1-Yr Rtn: | +7.53% | Ask: | 44.3000 |
Key Statistics for GSK
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | 11.5996 |
| Earnings Per Share (GBP) (ttm) | - |
| Est. EPS (GBP) (12/2012) | 2.4400 |
| Est. PEG Ratio | 1.2588 |
| Market Cap (M USD) | 111,252.99 |
| Shares Outstanding (M) | 2,512.49 |
| Enterprise Value (M GBP) (ttm) | - |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 4.9591 |
| Next Earnings Announcement | 07/25/2012 |
More GSK Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for GSK
- Operating
- Investing
- Financing (M/GBP)
Company Profile & Key Executives for GSK
GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.
| Christopher Charles GentChairman | Andrew WittyChief Executive Officer |
| Simon P DingemansChief Financial Officer | David RedfernChief Strategy Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page